Oglufanide
CAS No. 38101-59-6
Oglufanide( H-Glu-Trp-OH | L-Glutamyl-L-tryptophan )
Catalog No. M20677 CAS No. 38101-59-6
Oglufanide is a naturally occurring thymic immunomodulatorand inhibits vascular endothelial growth factor (VEGF).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 75 | In Stock |
|
| 5MG | 68 | In Stock |
|
| 10MG | 107 | In Stock |
|
| 25MG | 227 | In Stock |
|
| 50MG | 346 | In Stock |
|
| 100MG | 524 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameOglufanide
-
NoteResearch use only, not for human use.
-
Brief DescriptionOglufanide is a naturally occurring thymic immunomodulatorand inhibits vascular endothelial growth factor (VEGF).
-
DescriptionOglufanide is a naturally occurring thymic immunomodulatorand inhibits vascular endothelial growth factor (VEGF).
-
In Vitro——
-
In VivoAnimal Model:C57BL/6 immune competent mice, Lewis lung carcinoma (LLC) xenograft; Balb/C athymic mice, M21 human melanoma xenograftDosage:1, 10, 50 and 100 mg/kg/day Administration:Subcutaneous injection, 10 days Result:Resulted in a dose-dependent inhibition of LLC tumor growth in syngeneic immune competent mice and showed a dose-dependent decrease in tumor volumes of xenografts in Balb/C athymic mice implanted with M21 human melanoma cells.
-
SynonymsH-Glu-Trp-OH | L-Glutamyl-L-tryptophan
-
PathwayAngiogenesis
-
TargetVEGFR
-
RecptorVEGFR
-
Research AreaInfection
-
IndicationColorectal Cancer; Hepatitis C; Influenza virus infections; Kaposi's sarcoma; Ovarian Cancer
Chemical Information
-
CAS Number38101-59-6
-
Formula Weight333.34
-
Molecular FormulaC16H19N3O5
-
Purity>98% (HPLC)
-
SolubilityDMSO:15.5 mg/mL (46.50 mM)
-
SMILESN[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O
-
Chemical Name(S)-4-amino-5-(((S)-1-carboxy-2-(1H-indol-3-yl)ethyl)amino)-5-oxopentanoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Bayes M Rabasseda X Prous J R . Gateways to Clinical Trials[J]. Methods & Findings in Experimental & Clinical Pharmacology 2008 30(4):313.
molnova catalog
related products
-
Nintedanib
A potent triple angiokinase (VEGFR/PDGFR/FGFR) inhibitor with IC50 of 5/38/18/104/5 nM for VEGFR-2/FGFR-1/PDGFRα/VEGFR-1/VEGFR-3, respectively.
-
GW297361
GW297361 is a potent inhibitor of the cell cycle protein-dependent kinase Cdk1 and also inhibits the Pho85 signaling pathway.The IC50s of GW297361 on yeast Cdk1 and Pho85 were 20 nM and 400 nM, respectively.
-
N-Desethyl Sunitinib
N-Desethyl Sunitinib is a sunitinib metabolite.
Cart
sales@molnova.com